$7.1MRound, 18 February 2026
Round funds a permanent U.S. team and expansion of its QaiM drug discovery engine.
- Amount
- $7.1M
- Announced
- 18 February 2026
- Lead
- Heran Partners
- Other investors
- Clave Capital, Inveready, Bio&Tech Smart Capital
- Use of funds
- Round funds a permanent U.S. team and expansion of its QaiM drug discovery engine.
- Checked
- Announced by the company
- Sources
- Pharmacelera raises €6M to expand in US and advance quantum-AI platform (date approx) bolsamania.com
Pharmacelera raises €6M to expand in US and advance quantum-AI platform (date approx) pulse2.com